Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,648
Sort by:

Low Grade Serous Ovarian Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major low grade serous ovarian carcinoma markets reached a value of US$ 179.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 363.7 Million by 2034, exhibiting a growt...

May 2024 136 pages

Lower-Limb Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lower-limb spasticity markets are expected to exhibit a CAGR of 6.98% during 2024-2034. The lower-limb spasticity market has been comprehensively analyzed in IMARC's new report titled 'Low...

May 2024 130 pages

Lumbar Spondylolisthesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lumbar spondylolisthesis markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The lumbar spondylolisthesis market has been comprehensively analyzed in IMARC's new report title...

May 2024 140 pages

Lung Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lung adenocarcinoma markets reached a value of US$ 14.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 27.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 129 pages

Lupus Nephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lupus nephritis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.45%...

May 2024 134 pages

Lyme Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Lyme disease market reached a value of US$ 594.1 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 1,181.7 Mill...

May 2024 133 pages

Lymphadenopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphadenopathy markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The lymphadenopathy market has been comprehensively analyzed in IMARC's new report titled 'Lymphadenopathy...

May 2024 132 pages

Lymphangioleiomyomatosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphangioleiomyomatosis markets reached a value of US$ 87.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 125.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Lymphedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphedema markets reached a value of US$ 647.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,405.7 Million by 2034, exhibiting a growth rate (CAGR) of 7.3%...

May 2024 133 pages

Lymphoproliferative Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphoproliferative disorders markets are expected to exhibit a CAGR of 7.32% during 2024-2034. The lymphoproliferative disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 140 pages

Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Macular Edema market reached a value of US$ 3.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 5.8 Billion b...

May 2024 132 pages

Macular Telangiectasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major macular telangiectasia markets are expected to exhibit a CAGR of 6.7% during 2024-2034. The macular telangiectasia market has been comprehensively analyzed in IMARC's new report titled 'Ma...

May 2024 134 pages

Major Depressive Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The top 7 major depressive disorder markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.1 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 131 pages

Malignant Fibrous Histiocytoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant fibrous histiocytoma markets are expected to exhibit a CAGR of 8.67% during 2024-2034. The malignant fibrous histiocytoma market has been comprehensively analyzed in IMARC's new...

May 2024 133 pages

Malignant Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant mesothelioma markets reached a value of US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.2 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 135 pages

Malignant Pleural Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant pleural mesothelioma markets reached a value of US$ 318.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 632.6 Million by 2034, exhibiting a growth ra...

May 2024 137 pages

MALT Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malt lymphoma markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 7.98% du...

May 2024 129 pages

Mannosidase Deficiency Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mannosidase deficiency diseases markets are expected to exhibit a CAGR of 11.72% during 2024-2034. The mannosidase deficiency diseases market has been comprehensively analyzed in IMARC's n...

May 2024 135 pages

Mantle Cell Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mantle cell lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5...

May 2024 138 pages

Maple Syrup Urine Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major maple syrup urine disease markets are expected to exhibit a CAGR of 11.2% during 2024-2034. The maple syrup urine disease market has been comprehensively analyzed in IMARC's new report tit...

May 2024 128 pages

Marburg Virus Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major marburg virus disease markets are expected to exhibit a CAGR of 5.5% during 2024-2034. The Marburg virus disease market has been comprehensively analyzed in IMARC's new report titled 'Marb...

May 2024 138 pages

Marfan Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Marfan syndrome markets are expected to exhibit a CAGR of 5.17% during 2024-2034. The Marfan syndrome market has been comprehensively analyzed in IMARC's new report titled 'Marfan Syndrome...

May 2024 130 pages

Marginal Zone Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major marginal zone lymphoma markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Mastocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mastocytosis markets are expected to exhibit a CAGR of 3.41% during 2024-2034. The mastocytosis market has been comprehensively analyzed in IMARC's new report titled 'Mastocytosis Market:...

May 2024 134 pages

Medullary Thyroid Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major medullary thyroid cancer markets reached a value of US$ 141.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 405.1 Million by 2034, exhibiting a growth rate (CA...

May 2024 131 pages

Medulloblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major medulloblastoma markets are expected to exhibit a CAGR of 6.05% during 2024-2034. The medulloblastoma market has been comprehensively analyzed in IMARC's new report titled 'Medulloblastoma...

May 2024 136 pages

Meibomian Gland Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meibomian gland dysfunction markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major melanoma markets reached a value of US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.9 Billion by 2034, exhibiting a growth rate (CAGR) of 7.93% during...

May 2024 135 pages

MELAS Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The MELAS Syndrome market reached a value of US$ 154.8 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 447.7 Million by 203...

May 2024 138 pages

Membranous Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major membranous nephropathy markets reached a value of US$ 125.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 190.5 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 131 pages

Memory Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major memory disorders markets are expected to exhibit a CAGR of 5.42% during 2024-2034. The memory disorders market has been comprehensively analyzed in IMARC's new report titled 'Memory Disord...

May 2024 138 pages

Meniere's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Meniere's disease markets are expected to exhibit a CAGR of 2.38% during 2024-2034. The Meniere's disease market has been comprehensively analyzed in IMARC's new report titled 'Meniere's D...

May 2024 140 pages

Meningioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.79% durin...

May 2024 129 pages

Meningitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningitis markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The meningitis market has been comprehensively analyzed in IMARC's new report titled 'Meningitis Market: Epidemi...

May 2024 131 pages

Menkes Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Menkes disease markets are expected to exhibit a CAGR of 5.88% during 2024-2034. The Menkes disease market has been comprehensively analyzed in IMARC's new report titled 'Menkes Disease Ma...

May 2024 133 pages

Menorrhagia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major menorrhagia markets reached a value of US$ 970 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,380 Million by 2034, exhibiting a growth rate (CAGR) of 3.26% du...

May 2024 137 pages

Merkel Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Merkel cell carcinoma markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mesothelioma markets reached a value of US$ 434.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.91%...

May 2024 133 pages

Metabolic Acidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metabolic acidosis markets are expected to exhibit a CAGR of 5.76% during 2024-2034. The metabolic acidosis market has been comprehensively analyzed in IMARC's new report titled 'Metabolic...

May 2024 140 pages

Metachromatic Leukodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major metachromatic leukodystrophy markets reached a value of US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.2 Billion by 2034, exhibiting a growth rate (CA...

May 2024 133 pages

Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic castration-resistant prostate cancer markets are expected to exhibit a CAGR of 5.44% during 2024-2034. The metastatic castration-resistant prostate cancer market has been compre...

May 2024 138 pages

Metastatic Cutaneous Squamous Cell Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic cutaneous squamous cell cancer markets are expected to exhibit a CAGR of 5.64% during 2024-2034. The metastatic cutaneous squamous cell cancer market has been comprehensively an...

May 2024 140 pages

Metastatic Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic hepatocellular carcinoma markets are expected to exhibit a CAGR of 13.63% during 2024-2034. The metastatic hepatocellular carcinoma market has been comprehensively analyzed in I...

May 2024 135 pages

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic HER2-positive breast cancer markets are expected to exhibit a CAGR of 1.18% during 2024-2034. The metastatic HER2-positive breast cancer market has been comprehensively analyzed...

May 2024 138 pages

Metastatic Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic melanoma markets are expected to exhibit a CAGR of 8.23% during 2024-2034. The metastatic melanoma market has been comprehensively analyzed in IMARC's new report titled 'Metasta...

May 2024 132 pages

Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic prostate cancer markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The metastatic prostate cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Mild Cognitive Impairment Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mild cognitive impairment markets are expected to exhibit a CAGR of 4.02% during 2024-2034. The mild cognitive impairment market has been comprehensively analyzed in IMARC's new report tit...

May 2024 137 pages

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major minimal residual disease markets reached a value of US$ 855.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,261.0 Million by 2034, exhibiting a growth rate (...

May 2024 138 pages

Mitochondrial Myopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mitochondrial myopathies markets reached a value of US$ 22.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Mood Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mood disorders markets reached a value of US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 1.78% d...

May 2024 128 pages

Filters

Search

Categories

790
26
203
153
137
134
125
90
65,573
803
720
771
123

Publishers

179
1
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
370
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
239
536
361
1
1,357
60
1,696
8
8,921
2,215
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
297
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
787
495
2
2
2
117
191
102
53
23
700
26
133
522
174
622
64,679

Price

Date

Pages

Offers

1
280
1
1